Navigation Links
Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009
Date:10/27/2009

EAST RUTHERFORD, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) announced that third quarter 2009 financial results will be released on Tuesday, November 3, 2009 after the market closes.

The Company will host a conference call to discuss the third quarter 2009 financial results.

                     Third Quarter 2009 Earnings Conference Call

    When:            Wednesday, November 4, 2009 at 8:30 a.m. Eastern Time

    Dial-in:         1-888-634-4003 for U.S.
                     1-706-634-6653 for International
                     Pass code:  37211896

    Dial-in Replay:  1-800-642-1687 for U.S.
                     1-706-645-9291 for International
                     Pass code:  37211896
                     Available through Wednesday, November 11, 2009

    Webcast:         www.cambrex.com
                     Available for 30 days following the conference call

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. For more information, please visit www.cambrex.com.

SOURCE Cambrex Corporation


'/>"/>
SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Today Eli Lilly and Company (NYSE: LLY ... to increase the global supply of medicines for multidrug-resistant ... donating manufacturing technology and know-how for two antibiotics to ... India , Russia ... MDR-TB ,hot spots., It also served as the foundation ...
(Date:10/27/2014)... Research and Markets has announced the addition of ... their offering. H1N1 influenza (zoonotic) is an ... swine H1N1 virus, known as H1N1v virus. The H1N1v virus ... H1N1 virus is an RNA virus belonging to the Orthomyxoviridae ... humans, swine, birds, seals, and horses. Influenza A viruses can ...
(Date:10/27/2014)... EAST TAUNTON, Mass. , Oct. 27, 2014 /PRNewswire/ ... the $15 billion global hip and knee replacement device market, ... and knee replacement technology at the American Association of ... the Sheraton Dallas Hotel in Dallas, Texas ... is a Bronze corporate partner of the organization. ...
Breaking Medicine Technology:Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 2OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 3
... , LAKE FOREST, Ill. , Jan. 12 ... of injectable pharmaceuticals announced today the launch of Ibutilide ... from Pfizer Inc. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO ) , ... Pharma,s continued growth and dedication to a consistently expanding ...
... Jan. 12 CVS Caremark Corporation (NYSE: CVS ) ... quarterly dividend of approximately 15%, to 8.75 cents per share on ... holders of record on January 22, 2010 . This increase translates into ... cents per share from the previous rate of 30.5 cents . ...
Cached Medicine Technology:Bioniche Pharma Launches Ibutilide Fumarate Injection 2CVS Caremark Corporation Increases Quarterly Dividend 15% 2
(Date:10/30/2014)... The human brain is often overlooked ... to help maintain better mental health, according to Dr. ... Lose Your Memory in 100 Ways’ for just that ... conflicting attitudes to help keep the reader constantly thinking. ... must decipher the hidden logic within. , “If you ...
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
(Date:10/30/2014)... When it comes to heart disease, a new study finds ... they have symptoms that spell trouble. "The main danger ... more severe or advanced stage of heart disease, there are ... Fulbright Scholar and research fellow at the Harvard School of ... and Stroke Foundation of Canada. In the study, researchers ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 ... pregnancy may have effects on genital development in baby boys, ... born to moms with greater exposure to a chemical called ... space between the genitals and anus. Anogenital distance is set ... to androgens ("male" hormones) during pregnancy. The researchers said ...
(Date:10/30/2014)... Oct. 29, 2014 (HealthDay News) -- Many U.S. ... campus, even though tanning increases the risk for ... among young adults, particularly white women, so colleges ... health, the researchers said. "Public health efforts ... population awareness of the harms that indoor tanning ...
Breaking Medicine News(10 mins):Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... examines the use of tissue-engineered scaffolding made of cartilage cells, ... defective cartilage tissue. ,Cartilage cells are extracted ... body, where new cartilage tissue is grown along the structure. ... ,The procedure was extremely successful in tested mice as the ...
... between the immune systems of humans and opossums, the ... lead to breakthroughs in the understanding and treatment of ... found only in the Australian island state of Tasmania. ... full set of genetic information of the South American ...
... as to why oral cancer has been on the rise ... candidates . American scientists say that oral sex is a ... HPV between partners and may give cause to oral cancer ... any substance known to predispose to the disease. ...
... A new study reveals that almost two-thirds of ... their life, but very few of them experience ... certain emotional resilience in children, but it also suggests ... from adults, said William Copeland of Duke University Medical ...
... A new vaccine aimed at preventing cervical cancer is nearly ... papillomavirus (HPV) responsible for most cases of cervical cancer. ... published in the May 10 issue of the New England ... of young women, a series of three shots of a ...
... Research Hospital had a molecules eye view of the ... a double-strand break to link together the broken ... the twisted, ladder-like structure of DNA, breaking it into ... for this project, the St. Jude researchers could determine ...
Cached Medicine News:Health News:Treatment of Premature Babies, Opossums Could Help 2Health News:Swallowing The Bitter Pill-Oral Sex Linked To Oral Cancer 2Health News:Two-thirds of US Children Experience Trauma, but Recover Fast 2Health News:Study Shows Continued Success for New HPV Vaccine Against Virus 2Health News:DNA Repair Proteins Monitored at Double-strand Break 2
... The pause of a heartbeat. The bodys ... rhythmic breathing. These vital signs are yours ... DeRoyals line of Temperature Monitoring products helps ... information needed to provide the most comfortable ...
... Excilite- is a portable, compact, lightweight ... capable of emitting the same intensity (50 ... on a smaller treatment area (30 cm). ... order to satisfy the most demanding professional ...
... system used in neurophysiology for studying evoked potentials. ... and/or the duration of the stimulus as well ... emission in an ongoing manner by acting on ... include the high repeatability of the impulses, the ...
... 1.0 is a high power pulsed ... response to pain, even in the ... differs from the other laser devices ... full safety, all the 3 laser ...
Medicine Products: